Algernon Pharmaceuticals Inc.

AGNPFOTCHealthcare● Active

$0.44

+$0.01(+1.36%)

Market Cap$1541620

P/E Ratio—

52W High$0.713

52W Low$0.23

Avg Volume5K

Open$0.44

Beta0.91

Cash on Hand Financials Revenue

Algernon Pharmaceuticals Inc. (AGNPF) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

AGNPF · cash on hand · updated Aug 31, 2025

Core cash position

as of Aug 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$176,381▼ -70.4% vs prior year

FY · as of Aug 31, 2025 · Reported in CAD

Cash & Cash Equiv. (CCE)

$176,381

cashAndCashEquivalents

Short-Term Investments

shortTermInvestments

YoY Change vs Prior Year

-70.4%

vs prior fiscal year

Latest Quarter

$195,330

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in CAD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: August 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$176,381Cash on Hand

Total Debt$0Total Debt

Net Cash / Net Debt+$176,381Net Cash Position

Cash vs Debt Ratio

Cash 100%Algernon Pharmaceuticals Inc. cash as % of market cap: 11.44%% · MCap $0BDebt 0%

Algernon Pharmaceuticals Inc. has a net cash position of $176,381, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$176,381 − $0 = +$176,381

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

AGNPF annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

AGNPF cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Aug 31, 2025LatestFY$0.2M-70.4%

Aug 31, 2024FY$0.6M+376.6%

Aug 31, 2023FY$0.1M-91.1%

Aug 31, 2022FY$1.4M-41.6%

Aug 31, 2021FY$2.4M-60.6%

AGNPF cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

AGNPF vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Algernon Pharmaceuticals Inc.YOU

AGNPF

$0.2M$2M11.4%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Algernon Pharmaceuticals Inc. (AGNPF) cash on hand as of August 31, 2025 is $176,381, comprising $176,381 in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Algernon Pharmaceuticals Inc. cash and short-term investments on the balance sheet (10-K filing). Also referred to as Algernon Pharmaceuticals Inc. cash reserves or cash position.

Algernon Pharmaceuticals Inc. annual cash on hand history shows decreased -70.4% in 2025: decreased -70.4% in 2025. Algernon Pharmaceuticals Inc. cash reserves in 2025 reflect the company's capital allocation strategy.

Algernon Pharmaceuticals Inc. carries total debt of $0 against cash of $176,381, resulting in a net cash position of +$176,381. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

AGNPF cash on hand · 5 questions

As of August 31, 2025, Algernon Pharmaceuticals Inc. (AGNPF) has $176,381 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $176,381 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (February 28, 2026): $195,330. Data sourced from the annual 10-K filing via FMP.

AGNPF cash on handAGNPF cash reservesAGNPF cash 2025how much cash does AGNPF have

▸ Source: FMP /balance-sheet-statement · US GAAP · Algernon Pharmaceuticals Inc. · Algernon Pharmaceuticals Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: August 31, 2025